Literature DB >> 20321296

THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH DAGENAN (M. & B. 693).

D Graham1, W P Warner, J A Dauphinee, R C Dickson.   

Abstract

Year:  1939        PMID： 20321296      PMCID： PMC537091     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Sulphapyridine and Pneumococcal Infections.

Authors:  H L Marriott
Journal:  Br Med J       Date:  1939-11-11

2.  Renal Complications of Sulphapyridine: A Case which showed Gross Haematuria and Uraemia.

Authors:  J C Leedham-Green
Journal:  Br Med J       Date:  1941-04-19

3.  SULFAPYRIDINE IN EXPERIMENTAL PNEUMOCOCCIC PNEUMONIA IN THE DOG.

Authors:  L A Gregg; M Hamburger; C G Loosli
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

4.  [Animal experiments on the pathogenesis and localization of renal injury due to sulfonamide medication. I. Experimental sulfonamide nephrosis due to overdosage].

Authors:  E AUGUSTIN
Journal:  Arch Gynakol       Date:  1951

5.  ANURIA CAUSED BY SULFAPYRIDINE THERAPY : (Report of a Case Successfully Treated by Operation).

Authors:  E Smith; K A Evelyn; J F Nolan
Journal:  Can Med Assoc J       Date:  1940-01       Impact factor: 8.262

6.  Intensive Treatment of Gonorrhœa and Non-Specific Urethritis with Sulphapyridine.

Authors:  A J King; D I Williams
Journal:  Br J Vener Dis       Date:  1941-07

Review 7.  Issues in noninferiority trials: the evidence in community-acquired pneumonia.

Authors:  Thomas R Fleming; John H Powers
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

8.  THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE (DAGENAN).

Authors:  J M Kilgour
Journal:  Can Med Assoc J       Date:  1939-11       Impact factor: 8.262

Review 9.  Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.

Authors:  Brad Spellberg; George H Talbot; Eric P Brass; John S Bradley; Helen W Boucher; David N Gilbert
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

10.  Effect of M&B 693 and Uleron on the Blood.

Authors:  J S McCann
Journal:  Ulster Med J       Date:  1942-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.